Hennion & Walsh Asset Administration Inc. trimmed its holdings in Pfizer Inc. (NYSE:PFE – Free Report) by 11.7% throughout the third quarter, Holdings Channel.com reviews. The agency owned 39,587 shares of the biopharmaceutical firm’s inventory after promoting 5,256 shares throughout the interval. Hennion & Walsh Asset Administration Inc.’s holdings in Pfizer had been value $1,146,000 as of its most up-to-date submitting with the SEC.
A number of different hedge funds and different institutional buyers additionally just lately added to or lowered their stakes in PFE. Olistico Wealth LLC bought a brand new place in Pfizer throughout the second quarter valued at roughly $25,000. MFA Wealth Advisors LLC acquired a brand new place in shares of Pfizer within the 2nd quarter valued at $29,000. Quarry LP bought a brand new stake in Pfizer throughout the second quarter value $31,000. Monetary Connections Group Inc. acquired a brand new stake in Pfizer throughout the second quarter valued at $34,000. Lastly, ESL Belief Providers LLC bought a brand new place in Pfizer within the first quarter valued at $37,000. 68.36% of the inventory is owned by institutional buyers and hedge funds.
Analysts Set New Worth Targets
A number of equities analysis analysts have just lately issued reviews on PFE shares. Barclays elevated their goal worth on shares of Pfizer from $30.00 to $32.00 and gave the inventory an “equal weight” score in a analysis word on Wednesday, July thirty first. UBS Group boosted their worth goal on Pfizer from $30.00 to $31.00 and gave the corporate a “impartial” score in a analysis report on Wednesday, July thirty first. Daiwa Capital Markets raised shares of Pfizer from a “impartial” score to an “outperform” score and lifted their worth goal for the corporate from $28.00 to $34.00 in a analysis word on Wednesday, August seventh. Cantor Fitzgerald reaffirmed an “obese” score and set a $45.00 worth goal on shares of Pfizer in a report on Wednesday. Lastly, Citigroup began protection on shares of Pfizer in a analysis word on Friday. They set a “impartial” score and a $30.00 goal worth for the corporate. Eight equities analysis analysts have rated the inventory with a maintain score, six have assigned a purchase score and one has assigned a robust purchase score to the corporate. Based mostly on information from MarketBeat, Pfizer presently has a mean score of “Reasonable Purchase” and a mean worth goal of $33.58.
Learn Our Newest Inventory Evaluation on Pfizer
Pfizer Inventory Down 0.7 %
PFE inventory opened at $28.45 on Friday. The corporate has a present ratio of 0.86, a fast ratio of 0.60 and a debt-to-equity ratio of 0.65. The agency has a 50-day transferring common of $29.08 and a two-hundred day transferring common of $28.50. Pfizer Inc. has a 12 month low of $25.20 and a 12 month excessive of $31.54. The corporate has a market cap of $161.22 billion, a price-to-earnings ratio of -61.85, a PEG ratio of 1.01 and a beta of 0.67.
Pfizer (NYSE:PFE – Get Free Report) final posted its quarterly earnings outcomes on Tuesday, July thirtieth. The biopharmaceutical firm reported $0.60 EPS for the quarter, beating the consensus estimate of $0.46 by $0.14. The agency had income of $13.28 billion throughout the quarter, in comparison with analysts’ expectations of $12.96 billion. Pfizer had a constructive return on fairness of 8.42% and a damaging web margin of 4.66%. The enterprise’s income for the quarter was up 2.1% on a year-over-year foundation. Throughout the identical quarter final yr, the agency earned $0.67 earnings per share. As a bunch, analysts forecast that Pfizer Inc. will publish 2.67 earnings per share for the present fiscal yr.
Pfizer Dividend Announcement
The corporate additionally just lately disclosed a quarterly dividend, which will probably be paid on Monday, December 2nd. Buyers of document on Friday, November eighth will probably be issued a $0.42 dividend. This represents a $1.68 dividend on an annualized foundation and a dividend yield of 5.91%. The ex-dividend date is Friday, November eighth. Pfizer’s dividend payout ratio is at the moment -365.21%.
Pfizer Firm Profile
Pfizer Inc discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical merchandise in the US, Europe, and internationally. The corporate gives medicines and vaccines in varied therapeutic areas, together with cardiovascular metabolic, migraine, and girls’s well being below the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin household manufacturers; infectious illnesses with unmet medical wants below the Prevnar household, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba manufacturers; and COVID-19 prevention and therapy, and potential future mRNA and antiviral merchandise below the Comirnaty and Paxlovid manufacturers.
Beneficial Tales
Wish to see what different hedge funds are holding PFE? Go to HoldingsChannel.com to get the newest 13F filings and insider trades for Pfizer Inc. (NYSE:PFE – Free Report).
Obtain Information & Scores for Pfizer Day by day – Enter your electronic mail handle beneath to obtain a concise day by day abstract of the newest information and analysts’ rankings for Pfizer and associated firms with MarketBeat.com’s FREE day by day electronic mail e-newsletter.
